| . | CONV, n = 189 . | FT, n = 189 . | OR . | 95% CI . | P-Value . |
|---|---|---|---|---|---|
| Postoperative ventilation time (min), median (IQR) | 517.1 (320.2–905) | 165.5 (124.8–290.7) | – | – | <0.001 |
| ICU/PACU stay (h), median (IQR) | 21.7 (16.5–26.3) | 6.7 (33.7–21.6) | – | – | <0.001 |
| IMCU stay (h), median (IQR) | 33.1 (21.7–66.2) | 26.5 (19.9–51.2) | – | – | 0.2 |
| Hospital stay (days), median (IQR) | 11 (8–14) | 10 (8–13) | – | – | 0.3 |
| ICU re-admission, n (%) | 9 (4.8) | 11 (5.8) | 1.2 | 0.5–3.3 | 0.8 |
| IMCU re-admission, n (%) | 31 (16.4) | 17 (9) | 0.55 | 0.3–1.02 | 0.06 |
| Re-intubation, n (%) | 7 (3.7) | 1 (0.4) | 0.14 | 0.003–1.1 | 0.07 |
| Revision for bleeding, n (%) | 10 (5.3) | 10 (5.3) | 1 | 0.4–2.7 | 1 |
| Number of RBC units transfused, median (IQR) | 0 (0–2) | 0 (0–2) | – | – | 0.3 |
| Stroke, n (%) | 4 (2.1) | 2 (1.1) | 0.5 | 0.05–3.5 | 1 |
| Dialysis, n (%) | 7 (3.7) | 5 (2.6) | 0.7 | 0.2–2.6 | 0.8 |
| Postoperative PCI, n (%) | 0 (0) | 1 (0.5) | – | – | 1 |
| In-house mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| 30-Day mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| Follow-up (days), median (IQR) | 1952 (394–3057) | 394 (37–1447) | – | – | <0.001 |
| . | CONV, n = 189 . | FT, n = 189 . | OR . | 95% CI . | P-Value . |
|---|---|---|---|---|---|
| Postoperative ventilation time (min), median (IQR) | 517.1 (320.2–905) | 165.5 (124.8–290.7) | – | – | <0.001 |
| ICU/PACU stay (h), median (IQR) | 21.7 (16.5–26.3) | 6.7 (33.7–21.6) | – | – | <0.001 |
| IMCU stay (h), median (IQR) | 33.1 (21.7–66.2) | 26.5 (19.9–51.2) | – | – | 0.2 |
| Hospital stay (days), median (IQR) | 11 (8–14) | 10 (8–13) | – | – | 0.3 |
| ICU re-admission, n (%) | 9 (4.8) | 11 (5.8) | 1.2 | 0.5–3.3 | 0.8 |
| IMCU re-admission, n (%) | 31 (16.4) | 17 (9) | 0.55 | 0.3–1.02 | 0.06 |
| Re-intubation, n (%) | 7 (3.7) | 1 (0.4) | 0.14 | 0.003–1.1 | 0.07 |
| Revision for bleeding, n (%) | 10 (5.3) | 10 (5.3) | 1 | 0.4–2.7 | 1 |
| Number of RBC units transfused, median (IQR) | 0 (0–2) | 0 (0–2) | – | – | 0.3 |
| Stroke, n (%) | 4 (2.1) | 2 (1.1) | 0.5 | 0.05–3.5 | 1 |
| Dialysis, n (%) | 7 (3.7) | 5 (2.6) | 0.7 | 0.2–2.6 | 0.8 |
| Postoperative PCI, n (%) | 0 (0) | 1 (0.5) | – | – | 1 |
| In-house mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| 30-Day mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| Follow-up (days), median (IQR) | 1952 (394–3057) | 394 (37–1447) | – | – | <0.001 |
Continuous data: compared by Wilcoxon signed rank test; presented as median (interquartile range). Categorical data: compared by exact McNemar’s chi-squared test with continuity correction; reported as numbers (percentages). P < 0.05 indicates statistical significance.
CI: confidence interval; CONV: conventional treatment group; FT: fast-track treatment group; ICU: intensive care unit; IMCU: intermediate care unit; IQR: interquartile range; OR: odds ratio; PACU: postanaesthesia care unit; PCI: percutaneous coronary intervention; RBC: red blood cells.
| . | CONV, n = 189 . | FT, n = 189 . | OR . | 95% CI . | P-Value . |
|---|---|---|---|---|---|
| Postoperative ventilation time (min), median (IQR) | 517.1 (320.2–905) | 165.5 (124.8–290.7) | – | – | <0.001 |
| ICU/PACU stay (h), median (IQR) | 21.7 (16.5–26.3) | 6.7 (33.7–21.6) | – | – | <0.001 |
| IMCU stay (h), median (IQR) | 33.1 (21.7–66.2) | 26.5 (19.9–51.2) | – | – | 0.2 |
| Hospital stay (days), median (IQR) | 11 (8–14) | 10 (8–13) | – | – | 0.3 |
| ICU re-admission, n (%) | 9 (4.8) | 11 (5.8) | 1.2 | 0.5–3.3 | 0.8 |
| IMCU re-admission, n (%) | 31 (16.4) | 17 (9) | 0.55 | 0.3–1.02 | 0.06 |
| Re-intubation, n (%) | 7 (3.7) | 1 (0.4) | 0.14 | 0.003–1.1 | 0.07 |
| Revision for bleeding, n (%) | 10 (5.3) | 10 (5.3) | 1 | 0.4–2.7 | 1 |
| Number of RBC units transfused, median (IQR) | 0 (0–2) | 0 (0–2) | – | – | 0.3 |
| Stroke, n (%) | 4 (2.1) | 2 (1.1) | 0.5 | 0.05–3.5 | 1 |
| Dialysis, n (%) | 7 (3.7) | 5 (2.6) | 0.7 | 0.2–2.6 | 0.8 |
| Postoperative PCI, n (%) | 0 (0) | 1 (0.5) | – | – | 1 |
| In-house mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| 30-Day mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| Follow-up (days), median (IQR) | 1952 (394–3057) | 394 (37–1447) | – | – | <0.001 |
| . | CONV, n = 189 . | FT, n = 189 . | OR . | 95% CI . | P-Value . |
|---|---|---|---|---|---|
| Postoperative ventilation time (min), median (IQR) | 517.1 (320.2–905) | 165.5 (124.8–290.7) | – | – | <0.001 |
| ICU/PACU stay (h), median (IQR) | 21.7 (16.5–26.3) | 6.7 (33.7–21.6) | – | – | <0.001 |
| IMCU stay (h), median (IQR) | 33.1 (21.7–66.2) | 26.5 (19.9–51.2) | – | – | 0.2 |
| Hospital stay (days), median (IQR) | 11 (8–14) | 10 (8–13) | – | – | 0.3 |
| ICU re-admission, n (%) | 9 (4.8) | 11 (5.8) | 1.2 | 0.5–3.3 | 0.8 |
| IMCU re-admission, n (%) | 31 (16.4) | 17 (9) | 0.55 | 0.3–1.02 | 0.06 |
| Re-intubation, n (%) | 7 (3.7) | 1 (0.4) | 0.14 | 0.003–1.1 | 0.07 |
| Revision for bleeding, n (%) | 10 (5.3) | 10 (5.3) | 1 | 0.4–2.7 | 1 |
| Number of RBC units transfused, median (IQR) | 0 (0–2) | 0 (0–2) | – | – | 0.3 |
| Stroke, n (%) | 4 (2.1) | 2 (1.1) | 0.5 | 0.05–3.5 | 1 |
| Dialysis, n (%) | 7 (3.7) | 5 (2.6) | 0.7 | 0.2–2.6 | 0.8 |
| Postoperative PCI, n (%) | 0 (0) | 1 (0.5) | – | – | 1 |
| In-house mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| 30-Day mortality, n (%) | 3 (1.6) | 1 (0.5) | 3 | 0.01–4.2 | 0.6 |
| Follow-up (days), median (IQR) | 1952 (394–3057) | 394 (37–1447) | – | – | <0.001 |
Continuous data: compared by Wilcoxon signed rank test; presented as median (interquartile range). Categorical data: compared by exact McNemar’s chi-squared test with continuity correction; reported as numbers (percentages). P < 0.05 indicates statistical significance.
CI: confidence interval; CONV: conventional treatment group; FT: fast-track treatment group; ICU: intensive care unit; IMCU: intermediate care unit; IQR: interquartile range; OR: odds ratio; PACU: postanaesthesia care unit; PCI: percutaneous coronary intervention; RBC: red blood cells.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
